Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 1.82% | 27.93 | 14.1% | $164.34m | |
| ICLR | ICON plc | -0.61% | 224.27 | 4.2% | $149.09m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.21% | 175.90 | 2.2% | $133.34m | |
| HZNP | Horizon Therapeutics Plc | -0.96% | 86.56 | 5.5% | $116.43m | |
| CTLT | Catalent, Inc. | -2.34% | 101.57 | 2.1% | $105.74m | |
| BHC | Bausch Health Cos., Inc. | 1.82% | 27.93 | 0.0% | $88.73m | |
| SAVA | Cassava Sciences, Inc. | -4.44% | 37.49 | 0.0% | $55.76m | |
| UTHR | United Therapeutics Corp. | 0.61% | 195.49 | 14.0% | $55.68m | |
| PRGO | Perrigo Co. Plc | 3.29% | 45.80 | 6.9% | $44.37m | |
| BLRX | BioLineRx Ltd. | -7.60% | 2.92 | 0.8% | $39.46m | |
| ARGX | argenx SE | 0.37% | 258.21 | 0.0% | $38.07m | |
| SAGE | SAGE Therapeutics, Inc. | -0.38% | 73.88 | 7.6% | $35.36m | |
| PCRX | Pacira Biosciences, Inc. | 2.08% | 61.98 | 9.9% | $26.35m | |
| AXSM | Axsome Therapeutics, Inc. | -0.04% | 57.01 | 1.9% | $26.03m | |
| RVMD | Revolution Medicines, Inc. | 0.00% | 31.65 | 0.0% | $24.96m |
Company Profile
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which focuses on oncology. Its oncology programs include Motaxafortide (BL-8040), which is therapy platform used in the treatment of pancreatic cancer; and AGI-134 is a immunotherapy treatment used fro multiple solid tumors. The company was founded in April 2003 and is headquartered in Modi'in, Israel.